Navigation Links
BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
Date:12/4/2008

ng a drug reaction -- in front of us immediately. We can then perform a closer review of their lab data and medication profile to look or potential problems or needed adjustments and communicate that to their doctor."

"BAPTIST HEALTH has demonstrated the benefits a hospital pharmacy can realize by integrating our Micromedex Healthcare Solutions drug reference information with our CareFocus clinical surveillance solution," said Thomas Hegelund, executive vice president of the Healthcare business of Thomson Reuters. "With the help of our clinical consulting team they have integrated this solution across their entire system. Their clinicians now have real-time access to patient and drug information to make the best care decisions for their patients."

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance, and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare, and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries.

About BAPTIST HEALTH

BAPTIST HEALTH is Arkansas' most comprehensive health care system. With more than 180 access points -- including major medical centers, family clinics, and therapy and wellness centers -- BAPTIST HEALTH is committed to delivering "All Our Best" in healthcare to the people of Arkansas.


'/>"/>
SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Sentillion and Baptist Health System to Speak at Upcoming Gartner Identity & Access Management Summit
2. Baptist Health System Deploys Sentillions Vergence Solution to Provide Secure Identity and Access Management to 3,000 Clinicians
3. Leading Neurologist Opens Missouri Baptist Medical Centers First MS Center
4. Alabamas Baptist Health System and Aegis Health Group Partner to Address Local Employers Health-Management Concerns
5. BlueCross Recognizes Baptist Womens Hospital
6. Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum
7. Valley Baptist Health System Leveraging TITAN Technology Partners Hosting and Managed Services
8. Baptist Memorial Health Care Donates More Than $3 Million to Tennessee Universities and Colleges
9. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
10. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
11. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... from the Medical College of Wisconsin, in Milwaukee, found ... other sickle cell disease complications in children. Barriers to ... patients were also identified. The study led by ... at the Medical College and Children,s Research Institute at ... the American Society of Hematology meeting Dec. 7, 2009, ...
(Date:12/6/2009)... A new study provides welcome news for patients ... (VTE). , The condition is estimated to impact ... when an abnormal clot forms in a vein and ... In some cases, the clot may detach from its ... the lungs, causing a potentially fatal condition known as ...
(Date:12/5/2009)... three-drug combination has shown in a phase 1/2 ... in the treatment of patients newly diagnosed with multiple ... marrow, say researchers from Dana-Farber Cancer Institute. , Partial ... 66 patients treated with the drug combination in the ... partial response rate" in the phase 2 population, reports ...
(Date:12/5/2009)... Youngest Babies, This Type of Blood Cancer Is Most ... 5 Pediatric oncologists have identified specific genes, dubbed ... an often-fatal form of leukemia in infants. By more ... predict which infants may benefit from particular treatments. ...
(Date:12/5/2009)... and test their cleaning processes. The technology available to the lab ... problems for customers relating to cleaning parts, process development, and verification. ... ... Inc , a Jackson, MI-based company, is home to an advanced ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... Help Raise Funds, Awareness For Children,s Leukemia Foundation of ... Mich., March 17 Families of children affected by ... to a gift from the Chrysler Jeep Superstores that ... Michigan,s (CLFM) first annual telethon. The 18-hour telethon ...
... have been over-dramatized and have put increased pressure on ... in the Canadian Medical Association Journal ( ... from St. Michael,s Hospital and the University of Toronto ... British Columbia,s Fisheries Centre and author Farley Mowat to ...
... explain , , TUESDAY, March 17 (HealthDay News) -- A ... infertility, according to British researchers who found that the ... control the menstrual cycle. , The study included 10 ... to a hormone imbalance. The researchers injected the participants ...
... Flooring Systems and Amway Corporation now Offering ... Allergy Standards Ltd. (ASL), an Ireland-based, physician-led ... Flooring Systems and Amway Corporation have received ... Forbo Flooring Systems received the certification ...
... Keep Antibiotics Working (KAW) -- a national coalition ... advocacy groups with more than ten million supporters ... that would help combat the antibiotic resistance crisis ... human medicine in animal agriculture. The legislation, "The ...
... new computerized method of testing could help world health ... multiple strains of the disease. Rice University scientists who ... flu and seasonal flu outbreaks suggest their method can ... tests used today. , Rice,s Michael Deem, the lead ...
Other Medicine News:Health News:Families of Children Affected by Leukemia Get Boost of Support Thanks to Gift From Chrysler Jeep Superstores 2Health News:Fish health claims may cause more environmental harm than good: UBC-St. Michael's researchers 2Health News:Hormone Might Help Restore Female Fertility 2Health News:Ireland's Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products 2Health News:Rep. Slaughter Reintroduces Bill to Help Fight Antibiotic Resistance Crisis by Combating Misuse of Antibiotics in Animal Agriculture 2Health News:Better by design: Engineering flu vaccines 2
(Date:12/4/2009)... ,, PHILADELPHIA, Dec. 4 Teamster members ... Cross are hard at work educating the public about ... potentially put Philadelphia,s blood supply at risk. More ... a picket line yesterday when their issues were ignored ...
(Date:12/4/2009)... Dynatronics Corporation (Nasdaq: DYNT ) announced it has ... and rehab supplies to Benchmark Physical Therapy with 65 ... are pleased to be named the sole-source supplier to ... president of sales and marketing at Dynatronics. "Benchmark is ...
(Date:12/4/2009)... Dec. 4 Hospira, Inc. (NYSE: HSP ... company, today announced the launch of its next-generation 50 ... medications and solutions, and now offers a complete size ... environmentally responsible VisIV product. The launch of the 50 ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Mylans President of Europe Middle East and Africa Elected President of European Generic Medicines Association 6393 1Mylans President of Europe Middle East and Africa Elected President of European Generic Medicines Association 6393 2MS Need Not Preclude Pregnancy 61660 1MS Need Not Preclude Pregnancy 61660 2Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 1Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 2Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 3Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 4
... RIDGE, Colo., Nov. 24 GeneThera, Inc.,(Pink Sheets: GTHR.PK), announces ... Johne,s disease through its Wheat Ridge, Colo. laboratory. , ... offering its Johne,s disease testing service as,soon as January of ... "We expect to be offering our real time PCR test ...
... cancer treatment is,realizing outstanding results against pancreatic cancer. ... 4 tumor was reduced in size by 70%.,After ... could be definitely,identified on scans. Pancreatic cancer usually ... Innovation,s combination of FDA-approved drugs,appears to improve those ...
Other Medicine Technology:GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4New Cancer Treatment Shrinks Pancreatic Tumor 2
Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....
Antigenic Free Protein S, ELISA Method...
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies....
... Colorimetric Assay ... (UH) and Low ... (LMWH).Chromogenic substrate CBS ... freeze-dried; purified bovine ...
Medicine Products: